US FDA Cautions Against Blaming CRLs On Inspection Delays

 
• By Bowman Cox

Agency revises pandemic inspection guidance to explain CRL ‘non-deficiency’ inspection comments and update industry on remote interactive evaluations and post-COVID-19 inspection priorities.

FDA building
fda: delays are not deficiencies

More from Manufacturing

More from Compliance